Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Defensin beta 108E pseudogene (DEFB108E)
- Target
- DEFB108E
- Molecular classification
- Other
01
Overview
DEFB108E, or defensin beta 108E, is annotated as a pseudogene, meaning it is a non-functional segment of DNA similar to a gene but not expressed as a protein product due to accumulated mutations or other disruptions. Unlike other defensins, which are antimicrobial peptides involved in innate immunity, DEFB108E does not contribute to protein function, antimicrobial activity, or any known physiological process. Therefore, it is not considered a therapeutic target or biomarker, and no drugs or mechanisms of action are relevant for DEFB108E[3]. This distinguishes DEFB108E from functional beta-defensin peptides, which are antimicrobial, modulate immune responses, and have established biological roles, especially in epithelial and immune cell defense[1][2]. However, as a pseudogene, DEFB108E itself lacks these attributes and should not be used as a molecular target.
- Other names
- Defensin beta 108E (Pseudogene)DEFB108E
Beyond the preview
Go deeper on Defensin beta 108E pseudogene (DEFB108E).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Defensin beta 108E pseudogene (DEFB108E).